Related Experiment Video
Updated: Jan 23, 2026

Echocardiographic Measurement of Right Ventricular Diastolic Parameters in Mouse
Published on: April 27, 2019
Should We Test for Diastolic Dysfunction? How and How Often?
Sheldon E Litwin1, Michael R Zile1
1Department of Internal Medicine, Division of Cardiology, Medical University of South Carolina and the Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina.
Insights
Diagnosing heart failure (HF) involves assessing ventricular filling pressures. Direct measurement using implanted sensors is the only diastolic assessment proven to reduce HF hospitalizations.
Area of Science:
- Cardiology
- Medical Diagnostics
- Heart Failure Research
Background:
- Heart failure (HF) symptoms largely stem from elevated left and/or right ventricular filling pressures.
- Abnormal diastolic function, though difficult to define, contributes significantly to these elevated pressures.
- Diastolic dysfunction assessment aids in HF diagnosis, prognosis, and treatment guidance.
Purpose of the Study:
- To evaluate diagnostic and prognostic tools for heart failure related to diastolic dysfunction.
- To assess the efficacy of various methods in measuring or inferring ventricular filling pressures.
- To identify methods that can guide heart failure therapy and improve outcomes.
Main Methods:
- Review of existing evidence on echocardiographic parameters and serum natriuretic peptide levels.
- Analysis of the utility of inferior vena cava measurements in acute decompensated HF.
- Evaluation of direct left ventricular (LV) filling pressure measurements via implanted sensors.
Main Results:
- Individual echocardiographic parameters show weak correlation with direct LV filling pressures; combined parameters improve accuracy.
- Elevated serum natriuretic peptide levels are a key HF diagnostic criterion but lack evidence for guiding therapy.
- Direct LV filling pressure measurement via implanted sensors is the only "diastolic assessment" proven to reduce HF hospitalizations.
Conclusions:
- Current non-invasive methods have limitations in accurately guiding HF therapy.
- Further research is needed for serial echocardiography and natriuretic peptide monitoring.
- Implanted pressure sensors offer a proven method for reducing HF hospitalizations through direct diastolic pressure assessment.
Abstract:
Symptoms of heart failure (HF) are due in large part to elevation of left and/or right ventricular filling pressures. Although abnormal diastolic function is difficult to define, it contributes to the elevation of filling pressures. Tests that characterize aspects of diastolic function or structural changes associated with diastolic dysfunction, may help in establishing a diagnosis of HF, assessing prognosis, and guiding treatments. Individual echocardiographic parameters correlate weakly with LV (LV) filling pressures measured directly. However, a combination of multiple parameters improves accuracy for detection of elevated filling pressures. Serum natriuretic peptide levels are related to ventricular filling pressures and, when elevated, are a key diagnostic criterion for HF. Currently available evidence is not adequate to recommend serial echocardiographic studies or natriuretic peptide level measurements to assess changes in filling pressures or to guide HF therapy. Measurements of inferior vena cava size and dynamics have potential for identifying inadequate decongestion during episodes of acute decompensated HF but have not yet demonstrated utility in improving HF outcomes. Direct measurement of LV filling pressures using implanted pressure sensors is the only "diastolic assessment" thus far that has proven efficacy in reducing HF hospitalization rates.
More Related Videos
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023